Tech Company Financing Transactions

Unum Therapeutics Funding Round

Fairmount Funds Management, Acorn Bioventures and Ally Bridge Group participated in a $104.4 million venture round for Unum Therapeutics. The financing was announced on 7/10/2020.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Proceeds Purpose
The proceeds from the private placement will be used to advance clinical testing of PLX9486, a highly potent and selective KIT D816V inhibitor, in multiple indications and provide runway beyond 2022.

Company Information

Company Status
Private & Independent
Mailing Address
200 Cambridge Park Dr. 3100
Cambridge, MA 02140
Email Address
Unum Therapeutics uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body's own immune system to fight cancer.
Unum Therapeutics LinkedIn Company Profile
Social Media
Unum Therapeutics Company Twitter Account
Company News
Unum Therapeutics News
Unum Therapeutics on Facebook
Unum Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Chuck Wilson
  Chuck Wilson LinkedIn Profile  Chuck Wilson Twitter Account  Chuck Wilson News  Chuck Wilson on Facebook
Chief Financial Officer
John Green
  John Green LinkedIn Profile  John Green Twitter Account  John Green News  John Green on Facebook
Chief Medical Officer
Jessica Sachs
  Jessica Sachs LinkedIn Profile  Jessica Sachs Twitter Account  Jessica Sachs News  Jessica Sachs on Facebook
VP - Human Resources
Erin Schellhammer
  Erin Schellhammer LinkedIn Profile  Erin Schellhammer Twitter Account  Erin Schellhammer News  Erin Schellhammer on Facebook
VP - Operations
Larry Weiner
  Larry Weiner LinkedIn Profile  Larry Weiner Twitter Account  Larry Weiner News  Larry Weiner on Facebook
VP - R & D
Gregory Motz
  Gregory Motz LinkedIn Profile  Gregory Motz Twitter Account  Gregory Motz News  Gregory Motz on Facebook
VP - Regulatory Affairs
Todd Kenney
  Todd Kenney LinkedIn Profile  Todd Kenney Twitter Account  Todd Kenney News  Todd Kenney on Facebook



Browse more venture capital transactions:

Prev: 7/10/2020: Harbour BioMed venture capital transaction
Next: 7/10/2020: Orpyx Medical Technologies venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary